Scilex Holding Company
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
(0.0% 1d) (-14.0% 1m) (-90.4% 1y) (0.0% 2d) (0.0% 3d) (-8.6% 7d) (-25.1% volume)
Earnings Calendar:
Market Cap: $ 146,446,483
Sec Filling | Patents | n/a employees
add to watch list Paper trade email alert is off
Press-releases
Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses
Published: 2024-04-16 (Crawled : 13:00) - globenewswire.com
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
|
| O: -1.56%
H: 0.0%
C: -7.94%
ztlido sales first company opioid for commercial financial results
Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool
Published: 2024-04-09 (Crawled : 13:00) - globenewswire.com
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
|
| O: -7.28%
H: 7.86%
C: -2.86%
ztlido company group for
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend
Published: 2024-03-27 (Crawled : 13:00) - globenewswire.com
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
|
| O: -0.66%
H: 10.33%
C: 7.33%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -11.11%
H: 12.5%
C: 0.0%
company
Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients
Published: 2024-03-21 (Crawled : 13:30) - globenewswire.com
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
|
| O: 1.47%
H: 1.45%
C: 1.45%
company
Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed
Published: 2024-03-20 (Crawled : 15:00) - globenewswire.com
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
|
| O: 0.0%
H: 3.7%
C: 0.74%
gloperba fda label company renal approval
Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®
Published: 2024-03-20 (Crawled : 13:00) - globenewswire.com
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
|
| O: 0.0%
H: 3.7%
C: 0.74%
gloperba fda patent label company takeda resolve pharmaceuticals agreement
Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation
Published: 2024-03-19 (Crawled : 13:00) - globenewswire.com
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
|
| O: -0.73%
H: 4.41%
C: -0.74%
ORMP A | $2.265 2.96% 2.87% 110K
|
Health Technology
|
| O: -1.07%
H: 4.68%
C: 1.8%
company payment innovation growth
Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada
Published: 2024-03-18 (Crawled : 13:00) - globenewswire.com
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
|
| O: -0.73%
H: 3.31%
C: 0.74%
elyxyb drug patent company health approval review treatment canada migraine submission
Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB®
Published: 2024-03-18 (Crawled : 14:00) - biospace.com/
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
|
| O: -0.73%
H: 3.31%
C: 0.74%
elyxyb drug patent company health approval review canada submission
Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.
Published: 2024-03-15 (Crawled : 19:00) - globenewswire.com
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
| Email alert
Add to watchlist
ztlido certification
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10